News

TI Pharma researcher wins DSM Science & Technology award 2010

Laura Heitman, who earned her doctorate from the University of Leiden, was selected based on her PhD thesis entitled ‘Allosteric modulation of ‘reproductive’ GPCRs’. She has discovered a new approach to influence so-called GnRH- and LH- receptors, which are drug targets involved reproduction and several sex-hormone dependent diseases. This offers possibilities for new medicines which are less intrusive for the patient. Notably, this research was performed within the framework of TI Pharma as part of “The GPCR Forum: Novel concepts and tools for established targets”.

Purpose of the DSM Science & Technology Awards is to recognize and reward exceptional achievements of young researchers who are conducting innovative research with clear potential for practical applications. It consist of a first, second and third prize and a group of six fourth prize winners. Heitman received the fourth prize, consisting of an ‘Honorable Mention’ and prize of €1250. 

Laura Heitman continued as a TI Pharma researcher and is currently involved in another project: “Target residence time in translational drug research. The CCR2 chemokine receptor as a case in point.”